Search results
Researchers develop mRNA vaccine for strain of avian flu | Northwest Arkansas Democrat-Gazette
Northwest Arkansas Democrat Gazette· 3 days agoUniversity of Pennsylvania researchers have developed an mRNA vaccine for the H5N1 avian flu drawing increasing scrutiny by public health officials. The Penn team is using ...
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 5 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
Evolving With the Virus: Repeat COVID-19 Shots Neutralizing Beyond the Expected
SciTechDaily· 5 days agoCOVID-19 pandemic has ended, yet the virus responsible continues to circulate, hospitalizing...
Century-old vaccine found to protect type 1 diabetics from infectious diseases
Medical Xpress· 6 days agoTwo back-to-back randomized double-blinded placebo-controlled trials found that the BCG vaccine provided continuous protection for nearly the entire COVID
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters via Yahoo News· 4 days agoNovavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators...
COVID Is Rising in Bay Area Wastewater Again. Why? | KQED
KQED· 5 days agoNow, health officials must rely on a combination of wastewater data and hospital deaths of patients...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 5 days agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
Digital Journal· 6 days agoBy working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest ...
Better Buy: Inovio Pharmaceuticals vs. Novavax
The Motley Fool via AOL· 6 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer ...
Should You Buy This Stock After a Regulatory Setback? | The Motley Fool
The Motley Fool· 2 days agoThe past two-and-a-half years have been rough for Moderna (MRNA 1.58%). The company is developing...